Literature DB >> 15539707

Levels and values of serum high-sensitivity C-reactive protein within 6 hours after the onset of acute myocardial infarction.

Hon-Kan Yip1, Chiung-Jen Wu, Hsueh-Wen Chang, Cheng-Hsu Yang, Kuo-Ho Yeh, Sarah Chua, Morgan Fu.   

Abstract

BACKGROUND: C-reactive protein (CRP), which has been suggested to directly enhance inflammation in plaques, is rapidly synthesized and secreted in the liver 6 h after an acute inflammatory stimulus. Therefore, serum levels of CRP within 6 h after the onset of acute myocardial infarction (AMI) merely reflect a chronic and persistent inflammatory process and are not due to acute myocardial damage. We hypothesized that the serum CRP level, which would abnormally elevate thereafter, is followed by a plaque rupture in the clinical setting of AMI. METHODS AND
RESULTS: CRP was prospectively measured by high-sensitivity CRP assay (hs-CRP) in 157 consecutive patients (106 patients within 6 h, and 51 patients >/= 6 h but < 12 h after the onset of AMI) with ST-segment elevation AMI undergoing primary percutaneous coronary intervention (PCI). Serum levels of hs-CRP were also measured in 30 patients with stable angina undergoing elective PCI and in 30 healthy control subjects. The serum level of hs-CRP was significantly higher in patients with an onset of AMI < 6 h than in patients with angina pectoris (2.7 +/- 2.3 mg/L vs 1.4 +/- 0.7 mg/L, p < 0.0001 [mean +/- SD]) and in healthy subjects (2.7 +/- 2.3 mg/L vs 1.0 +/- 0.6 mg/L, p < 0.0001). There were no significant differences in serum levels of hs-CRP in patients with an onset of AMI </= 3 h than in those patients with an onset of AMI > 3 h but < 6 h (2.7 +/- 2.5 mg/L vs 2.7 +/- 2.2 mg/L, p = 0.87). However, the serum level of hs-CRP was significantly higher in patients with an onset >/= 6 h than in patients with an onset < 6 h (14.1 +/- 16.5 mg/L vs 2.7 +/- 2.3 mg/L, p < 0.0001).
CONCLUSIONS: Serum levels of hs-CRP were significantly higher in patients with an onset of AMI < 6 h than in healthy subjects and in patients with angina pectoris undergoing PCI. The inflammatory process has been proved as one of the mechanisms causing plaque rupture. Elevated serum hs-CRP levels in patients with AMI < 6 h may portend vulnerable plaque rupture.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15539707     DOI: 10.1378/chest.126.5.1417

Source DB:  PubMed          Journal:  Chest        ISSN: 0012-3692            Impact factor:   9.410


  14 in total

1.  Early detection of C-reactive protein and von Willebrand factor levels in Malaysian patients with acute coronary syndrome.

Authors:  Wen Ni Tiong; Edmund Ui Hang Sim; Alan Yean Yip Fong; Tiong Kiam Ong
Journal:  J Cardiovasc Dis Res       Date:  2013-02-27

2.  Intensive statin therapy in acute coronary syndromes and stable coronary heart disease: a comparative meta-analysis of randomised controlled trials.

Authors:  Jonathan Afilalo; Agnieska A Majdan; Mark J Eisenberg
Journal:  Heart       Date:  2007-02-03       Impact factor: 5.994

3.  Circulating soluble CD40 ligand mediates the interaction between neutrophils and platelets in acute coronary syndrome.

Authors:  Budi Y Setianto; Anggoro B Hartopo; Putrika P R Gharini; Dyah W Anggrahini; Bambang Irawan
Journal:  Heart Vessels       Date:  2010-07-31       Impact factor: 2.037

4.  Circulating microparticles enhanced rat vascular wall remodeling following endothelial denudation.

Authors:  Fan-Yen Lee; Hung-I Lu; Han-Tan Chai; Jiunn-Jye Sheu; Yi-Ling Chen; Tein-Hung Huang; Gour-Shenq Kao; Sheng-Yi Chen; Sheng-Ying Chung; Pei-Hsun Sung; Hsueh-Wen Chang; Mel S Lee; Hon-Kan Yip
Journal:  Am J Transl Res       Date:  2016-11-15       Impact factor: 4.060

5.  Baseline clinical characteristics and midterm prognosis of STE-ACS and NSTE-ACS patients with normal coronary arteries.

Authors:  Lukasz Mazurkiewicz; Zofia T Bilinska; Mariusz Kruk; Andrzej Ciszewski; Jacek Grzybowski; Adam Witkowski; Witold Ruzyllo
Journal:  Ann Noninvasive Electrocardiol       Date:  2009-01       Impact factor: 1.468

6.  Combination of cilostazol and clopidogrel attenuates rat critical limb ischemia.

Authors:  Jiunn-Jye Sheu; Kun-Chen Lin; Ching-Yen Tsai; Tzu-Hsien Tsai; Steve Leu; Chia-Hung Yen; Yung-Lung Chen; Hsueh-Wen Chang; Cheuk-Kwan Sun; Sarah Chua; Jenq-Lin Yang; Hon-Kan Yip
Journal:  J Transl Med       Date:  2012-08-16       Impact factor: 5.531

7.  Effect of obesity reduction on preservation of heart function and attenuation of left ventricular remodeling, oxidative stress and inflammation in obese mice.

Authors:  Hui-Ting Wang; Chu-Feng Liu; Tzu-Hsien Tsai; Yung-Lung Chen; Hsueh-Wen Chang; Ching-Yen Tsai; Steve Leu; Yen-Yi Zhen; Han-Tan Chai; Sheng-Ying Chung; Sarah Chua; Chia-Hung Yen; Hon-Kan Yip
Journal:  J Transl Med       Date:  2012-07-11       Impact factor: 5.531

8.  Association between inflammatory biomarkers and thin-cap fibroatheroma detected by optical coherence tomography in patients with coronary heart disease.

Authors:  Kohei Koyama; Kihei Yoneyama; Takanobu Mitarai; Yuki Ishibashi; Eiji Takahashi; Ken Kongoji; Tomoo Harada; Yoshihiro J Akashi
Journal:  Arch Med Sci       Date:  2015-06-19       Impact factor: 3.318

9.  Lipid profile of patients with acute myocardial infarction and its correlation with systemic inflammation.

Authors:  Haseeb A Khan; Abdullah S Alhomida; Samia H Sobki
Journal:  Biomark Insights       Date:  2013-01-24

10.  Levels and values of lipoprotein-associated phospholipase A2, galectin-3, RhoA/ROCK, and endothelial progenitor cells in critical limb ischemia: pharmaco-therapeutic role of cilostazol and clopidogrel combination therapy.

Authors:  Jiunn-Jye Sheu; Pao-Yuan Lin; Pei-Hsun Sung; Yi-Ching Chen; Steve Leu; Yung-Lung Chen; Tzu-Hsien Tsai; Han-Tan Chai; Sarah Chua; Hsueh-Wen Chang; Sheng-Ying Chung; Chih-Hung Chen; Sheung-Fat Ko; Hon-Kan Yip
Journal:  J Transl Med       Date:  2014-04-17       Impact factor: 5.531

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.